Alnylam director granted RSUs and stock options
ALNYLAM PHARMACEUTICALS, INC. director Olivier Brandicourt reported compensation-related equity awards, not open-market trades.
Rhea-AI Filing Summary
ALNYLAM PHARMACEUTICALS, INC. director Olivier Brandicourt reported compensation-related equity awards, not open-market trades. He received 671 shares of common stock in the form of restricted stock units granted at no cash cost.
Brandicourt was also granted stock options for 1,441 shares of common stock at an exercise price of $298.48 per share. Both the RSUs and the options vest in full on the earlier of the first anniversary of the May 20, 2026 grant date or his earlier retirement or resignation, if that occurs no more than 90 days before the first anniversary. Following these awards, he directly holds 1,446 common shares and 1,441 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 2,112 shares
Grant/Award
2 txns
Insider
BRANDICOURT OLIVIER
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,441 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 671 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,441 contracts (Direct);
Common Stock — 1,446 shares (Direct)
Footnotes (2)
- F1. These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
- F2. The stock option will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
Key Figures
RSU grant: 671 shares
Option grant size: 1,441 options
Option exercise price: $298.48/share
+2 more
5 metrics
RSU grant
671 shares
Restricted stock units granted May 20, 2026
Option grant size
1,441 options
Stock options for common stock granted May 20, 2026
Option exercise price
$298.48/share
Conversion or exercise price for 1,441 stock options
Shares after grant
1,446 shares
Common stock directly held after RSU award
Option expiration
May 20, 2036
Expiration date of stock options
Key Terms
restricted stock units (RSUs), Second Amended and Restated 2018 Stock Incentive Plan, Stock Option (Right to Buy), exercise price
4 terms
restricted stock units (RSUs) financial
"These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Second Amended and Restated 2018 Stock Incentive Plan financial
"RSUs granted under the Second Amended and Restated 2018 Stock Incentive Plan."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 298.4800."
exercise price financial
"conversion_or_exercise_price: "298.4800" for the stock option grant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did ALNY director Olivier Brandicourt report?
Olivier Brandicourt reported equity awards, not market trades. He received 671 restricted stock units and stock options for 1,441 shares, both granted on May 20, 2026 as part of his director compensation package.
What are the terms of Olivier Brandicourt’s ALNY stock options?
Brandicourt was granted options on 1,441 ALNY shares at an exercise price of $298.48. The options vest fully on the first anniversary of the May 20, 2026 grant date or earlier qualifying retirement or resignation, and expire on May 20, 2036.
When do Olivier Brandicourt’s ALNY RSUs and options vest?
Both the 671 RSUs and 1,441 stock options vest in full on the earlier of the first anniversary of the May 20, 2026 grant date or the date of his retirement or resignation, if that occurs within 90 days before that anniversary.
Are Olivier Brandicourt’s ALNY equity awards open-market purchases or sales?
They are not open-market trades. The Form 4 shows compensation-related grants: 671 restricted stock units and 1,441 stock options, both awarded at a grant price of $0.00, with a separate $298.48 exercise price for the options.
AI-generated analysis. How Rhea-AI works. Not financial advice.
